Bayer Statement on Solicitor General’s Amicus Brief in the Hardeman Appeal
Bayer today issued the following statement on the Solicitor General’s Amicus Brief in the Hardeman appeal.
Bayer today issued the following statement on the Solicitor General’s Amicus Brief in the Hardeman appeal.
Bayer today released the following statement on the Shelton Roundup™ product liability trial before Judge Charles H. McKenzie in the Circuit Court of Jackson County, Missouri at Kansas City.
Today Monsanto filed a petition for certiorari with the U.S. Supreme Court in its appeal of the Pilliod verdict. Bayer’s statement on the filing is as follows.
Today the U.S. Supreme Court issued an order in Monsanto Co. v. Hardeman requesting the views of the Solicitor General on behalf of the United States. Bayer issued the following statement in response.
Bayer today released the following statement on the defense verdict in Stephens.
Bayer today released the following statement on the verdict in the Clark trial in the Superior Court of California, County of Los Angeles.
Bayer today released the following statement on the beginning of the Clark Trial in the Superior Court of California, County of Los Angeles.
Today Bayer – through its subsidiary Monsanto – filed its Petition for a Writ of Certiorari with the U.S. Supreme Court in Hardeman, the only Roundup™ federal product liability case to have gone to trial.
Bayer today released the following statement on decision in the Pilliod appeal before the Court of Appeal of the State of California.
Bayer today released the following statement on the beginning of the Stephens Trial in the Superior Court of California, County of San Bernardino.
Bayer continues to make progress on its five-point plan to manage and mitigate the risks of Roundup™ litigation in the U.S. We settled most of the claims in this litigation and have appropriately provisioned for the remaining claims. Having won most trials, the company will continue to try cases based on decades of science and worldwide regulatory assessments that continue to support Roundup’s safety and non-carcinogenicity.
Read more about the five-point plan here.